Insider Trading History of Henn Matthew R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Henn Matthew R since 2020. This trader's CIK number is 1767321. At the time of last reporting, Henn Matthew R was the See Remarks of Seres Therapeutics, Inc.. (stock ticker symbol MCRB). Also see all insider trading activities at Seres Therapeutics, Inc..


Yearly summary of insider trading at Seres Therapeutics, Inc. (MCRB) by Henn Matthew R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 MCRB 0 $0 4,103 $4,976 11,102 $0
2024 MCRB 0 $0 10,895 $9,364 32,309 $0
2023 MCRB 0 $0 3,886 $5,246 12,623 $0
2020 MCRB 0 $0 91,812 $2,523,636 87,312 $441,919


Insider trading of Seres Therapeutics, Inc. (MCRB) by Henn Matthew R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-18 MCRB Sale 73 16.65 1,215
2025-08-15 MCRB Option Ex 238 .00 0
2025-05-16 MCRB Sale 77 7.28 560
2025-05-15 MCRB Option Ex 238 .00 0
2025-02-15 MCRB Option Ex 10,626 .00 0
2025-02-18 MCRB Sale 3,953 .81 3,201
2024-11-15 MCRB Option Ex 2,812 .00 0
2024-11-18 MCRB Sale 927 .54 501
2024-10-27 MCRB Option Ex 12,622 .00 0
2024-10-28 MCRB Sale 3,984 .69 2,748
2024-08-16 MCRB Sale 923 .84 775
2024-08-15 MCRB Option Ex 2,813 .00 0
2024-05-15 MCRB Sale 891 .94 837
2024-05-15 MCRB Option Ex 2,812 .00 0
2024-02-15 MCRB Option Ex 11,250 .00 0
2024-02-16 MCRB Sale 4,170 1.08 4,503
2023-10-30 MCRB Sale 3,886 1.35 5,246
2023-10-27 MCRB Option Ex 12,623 .00 0
2020-12-01 MCRB Option Ex 79,812 5.54 441,919
2020-12-01 MCRB Sale 91,812 27.49 2,523,636
2020-01-26 MCRB Option Ex 7,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henn Matthew R (See Remarks of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.